# Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age

> **NCT00192140** · PHASE4 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 345 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** FluMist

## Key facts

- **NCT ID:** NCT00192140
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2004-10
- **Final completion:** 2005-01
- **Target enrollment:** 345 (—)
- **Last updated:** 2007-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00192140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00192140, "Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00192140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*